NCT02285361View on ClinicalTrials.gov

GIOTRIF rPMS in Korean Patients With NSCLC

CompletedOBSERVATIONAL
Enrollment

1,272

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

GIOTRIF 20mg

NSCLC with GIOTRIF 20mg

DRUG

GIOTRIF 40mg

NSCLC with GIOTRIF 40mg

DRUG

GIOTRIF 30mg

NSCLC with GIOTRIF 30mg

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY